SAM CHUN DANG PHARM CO. LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 000250 for the last quarter is 54.89 B KRW, and it's 13.27% higher compared to the previous quarter. The net income of Q2 24 is 174.06 M KRW.